• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素激动剂触发后黄体支持时机的理论依据

A Rationale for Timing of Luteal Support Post Gonadotropin-Releasing Hormone Agonist Trigger.

作者信息

Kol Shahar

机构信息

IVF Unit, Elisha Hospital, Haifa,

出版信息

Gynecol Obstet Invest. 2019;84(1):1-5. doi: 10.1159/000491088. Epub 2018 Jul 13.

DOI:10.1159/000491088
PMID:30007966
Abstract

Gonadotropin-releasing hormone (GnRH) antagonist-based ovarian stimulation protocol is gaining popularity. This protocol allows for the use of GnRH agonist as a trigger of final oocyte maturation, instead of the "gold standard" human chorionic gonadotropin (hCG) trigger. GnRH agonist trigger causes quick luteolysis, hence its widespread use in the context of ovarian hyperstimulation syndrome (OHSS) prevention. To secure pregnancy post GnRH agonist trigger, the luteal phase must be supplemented to counteract the luteolysis. Several luteal phase protocols post GnRH agonist trigger have been suggested, most notably based on increasing luteal luteinizing hormone (LH) activity (by adding LH or hCG). The current review aims at delineating a rationale for timing luteal support with a single hCG bolus post GnRH agonist trigger. The review also suggests a set of simple rules that must be followed when designing luteal phase support post GnRH agonist trigger.

摘要

基于促性腺激素释放激素(GnRH)拮抗剂的卵巢刺激方案正日益受到欢迎。该方案允许使用GnRH激动剂作为最终卵母细胞成熟的触发剂,而不是“金标准”人绒毛膜促性腺激素(hCG)触发剂。GnRH激动剂触发会导致快速黄体溶解,因此其在预防卵巢过度刺激综合征(OHSS)的背景下被广泛使用。为了在GnRH激动剂触发后确保妊娠,必须补充黄体期以抵消黄体溶解。已经提出了几种GnRH激动剂触发后的黄体期方案,最显著的是基于增加黄体期促黄体生成素(LH)活性(通过添加LH或hCG)。本综述旨在阐述在GnRH激动剂触发后用单次hCG推注进行黄体支持的时机的基本原理。该综述还提出了一组在设计GnRH激动剂触发后的黄体期支持时必须遵循的简单规则。

相似文献

1
A Rationale for Timing of Luteal Support Post Gonadotropin-Releasing Hormone Agonist Trigger.促性腺激素释放激素激动剂触发后黄体支持时机的理论依据
Gynecol Obstet Invest. 2019;84(1):1-5. doi: 10.1159/000491088. Epub 2018 Jul 13.
2
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.对于有卵巢过度刺激综合征风险且正在接受控制性卵巢刺激的患者,采用促性腺激素释放激素激动剂触发排卵并积极进行黄体期支持。
Taiwan J Obstet Gynecol. 2015 Oct;54(5):583-7. doi: 10.1016/j.tjog.2015.08.012.
3
Gonadotropin Releasing Hormone Agonist Final Oocyte Maturation and Human Chorionic Gonadotropin as Exclusive Luteal Support in Normal Responders.促性腺激素释放激素激动剂用于最终卵母细胞成熟及人绒毛膜促性腺激素作为正常反应者唯一的黄体支持
Gynecol Obstet Invest. 2019;84(1):27-34. doi: 10.1159/000490946. Epub 2018 Jul 26.
4
Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases.体外受精患者在使用促性腺激素释放激素激动剂触发并遵循“全冻策略”且无黄体期支持的情况下未出现黄体期缺陷及自然妊娠:四例报告
Gynecol Endocrinol. 2016;32(1):18-20. doi: 10.3109/09513590.2015.1110694. Epub 2015 Nov 16.
5
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.在接受重组促卵泡激素和促性腺激素释放激素(GnRH)拮抗剂联合治疗进行卵巢刺激后的体外受精患者中,给予重组人绒毛膜促性腺激素、重组促黄体生成素或GnRH激动剂诱导最终卵母细胞成熟后,未补充黄体期的特征。
J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953.
6
The prevention of ovarian hyperstimulation syndrome.卵巢过度刺激综合征的预防
J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5.
7
Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.在人绒毛膜促性腺激素释放激素激动剂扳机时给予低剂量人绒毛膜促性腺激素与在有发生卵巢过度刺激综合征高危风险的妇女中在 35 小时后给予相比 - 一项前瞻性随机双盲临床试验。
J Ovarian Res. 2019 Jan 26;12(1):8. doi: 10.1186/s13048-019-0483-7.
8
Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.在重组促卵泡激素刺激和 GnRH 拮抗剂共同治疗的 IVF 周期中,触发卵母细胞最终成熟的方式会影响黄体早期的子宫内膜基因表达。
Hum Reprod. 2012 Nov;27(11):3259-72. doi: 10.1093/humrep/des279. Epub 2012 Aug 28.
9
Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial.在激动剂触发周期中寻求最佳黄体支持方式:一项随机临床试验。
Hum Reprod. 2018 Jun 1;33(6):1079-1086. doi: 10.1093/humrep/dey054.
10
Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome.对有高风险发生卵巢过度刺激综合征的患者使用促性腺激素释放激素激动剂进行促排卵和黄体支持。
Gynecol Endocrinol. 2015;31(9):693-7. doi: 10.3109/09513590.2015.1025379. Epub 2015 Aug 31.

引用本文的文献

1
Luteal phase support in fresh and frozen embryo transfers.新鲜胚胎移植和冷冻胚胎移植中的黄体期支持。
Front Reprod Health. 2022 Jul 19;4:919948. doi: 10.3389/frph.2022.919948. eCollection 2022.
2
Ovarian protection and safety of gonadotropin-releasing hormone agonist after cervical cancer surgery: systematic review and meta-analysis.宫颈癌手术后促性腺激素释放激素激动剂的卵巢保护作用及安全性:系统评价与Meta分析
Ann Transl Med. 2022 Apr;10(7):409. doi: 10.21037/atm-22-928.
3
The inadequate corpus luteum.黄体功能不足。
Reprod Fertil. 2021 Feb 26;2(1):C1-C7. doi: 10.1530/RAF-20-0044. eCollection 2021 Jan.
4
Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial.GnRH 激动剂触发的 ICSI 周期后黄体期支持中每日 GnRH 激动剂与常规方案的疗效比较:一项随机对照试验。
JBRA Assist Reprod. 2021 Jul 21;25(3):368-372. doi: 10.5935/1518-0557.20200077.